Plant Medicine Clinic Announces New Medicinal Cannabinoids Research Programs In Australia

Cloud Medical has announced new medical cannabinoid research programs. The organization believes that this will unlock a variety of therapeutic benefits for patients across the country.

West Perth, Australia – January 10, 2023 —

Cloud Medical is pleased to announce new medical cannabinoid research programs in Australia. Australia is already at the forefront of medicinal plant-based research, leading the way with a variety of groundbreaking medical advancements. 

Cloud Medical’s medical cannabinoid research program is the latest step. The program aims to explore the potential therapeutic benefits of medicinal cannabinoids in treating a wide range of serious illnesses and conditions. 

Medical cannabinoids are compounds sourced from cannabis plants that are proven to provide health benefits. These compounds are able to interact with our endocannabinoid system which helps regulate various functions in the body. As such, by stimulating the system using the compounds, it is possible to reduce inflammation and pain while reducing issues with anxiety or depression. 

By investing in a comprehensive research program for medical cannabinoids, Cloud Medical believes they could potentially unlock countless for people experiencing a variety of medical conditions. The clinic suggests this could lead to improved quality of life for those suffering from chronic illnesses or a range of conditions. 

Moreover, the clinic believes this research program could help pave the way for further advancements in medical science by enabling researchers to gain valuable insights into how different cannabinoids interact with each other and how they can be used together for maximum benefit. They also claim it could open up new possibilities when it comes to discovering novel treatments or therapies that weren’t previously available.  

Dr Kane Della Vedova is an authorised prescriber ad Medicinal and the pioneer behind the new cannabinoid research program. He said:

“The launch of the cannabinoid research program is an exciting development in the field of medicine and one that we should all pay close attention to. By conducting more clinical trials and studies on medicinal cannabis products, Cloud Medical can gain invaluable insight into their potential therapeutic benefits and ultimately improve the quality of life for those suffering from serious illnesses or debilitating conditions. 

He added: 

“For patients looking for pain relief or symptom management without relying on traditional medications, this program could provide much-needed hope.” 

About Cloud Medical 

Cloud Medical is run by a team of authorised prescribers of plan-based medicine who research the maximum outcomes for patients. The clinic provides telehealth consultations as well as express delivery of all the plant medicine they prescribe. 

The team behind the clinic believe that new medicinal cannabinoid research programs are key to providing a better quality of life for their patients. 

More information about Cloud Medical can be found on the clinic website. Alternatively, Dr Kane can be contacted directly using the information provided below. 

Contact Info:
Name: Dr Kane Della Vedova
Email: Send Email
Organization: Cloud Medical
Address: 59 Malcolm Street, West Perth 6005
Phone: ​​0893346989
Website: https://cloudmedical.clinic/

Release ID: 89087862

If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.